About us-TriApex

Build a world-famous and domestic
advanced CRO that enables
the disease-oriented R&D.

group profile

Provide global pharmaceutical enterprises and research institutions with new drug R&D in disease-oriented fields

TriApex Laboratories Co., Ltd. (TriApex), founded in 2008, is an innovative CRO dedicated to providing disease-oriented integrated solutions to enable the R&D for global pharmaceutical enterprises and research institutions.

TriApex takes scientific research, enabling new drug R&D, and improving quality of patients’ life as its own mission. Relying on the top technical service team in the industry, TriApex builds and improves group management, focuses on the pathogenesis and models of diseases, nonclinical research, and clinical and translational research by means of highly scientific and professional operation strategies.

TriApex, taking advantage of its excellent service quality and abundant industry experience, powers innovation of technologies, leads industry innovation, and consistently forges ahead on the road to promoting human health development.

Technical Team

40

+

Doctors

150

+

Masters

7

Toxicologists

8

DACVPs

5

CSQAs

Vision

Innovative CRO enabling new drug R&D in disease-oriented fields

Missions

Dedicated to scientific assessment, enabling transformation of innovation, and improving quality of life

Values

Integrity Dedication Cooperation Excellence

Partners

TriApex owns 500+ outstanding partners in the world, and this number is still rapidly increasing.

In deep participation in various projects, TriApex, relying on increasing experiences and accumulative methods, continues to enable disease-oriented R&D and has unique advantages in promoting its own and the industry's innovative transformation.

500 +

domestic/overseas outstanding partners

TOP20

Deep cooperation with TOP20 global pharmaceutical enterprises

200 +

Experience in cooperation with 200+ national clinical research centers

Members of TriApex

TriApex Nanjing

Industry-leading CRO providing one-stop solutions

TriApex, founded in 2008, is a contract research organization (CRO) providing pharmaceutical R&D services. We are dedicated to providing nonclinical services including pharmacokinetics studies, safety assessment and biological sample analysis of traditional Chinese medicine, chemical and biotech drugs for domestic and global pharmaceutical R&D institutions, which comply with submission requirements for international application (NMPA/FDA).

Learn more

Kunming Biomed (KBI)

TriApex Med

TriApex Biotechnology

Harborside

History

2008

founded in 2008.

2011

certificated by CFDA for conduct of GLP studies.

2012

accredited by AAALAC.

2016

conducted non-clinical studies supporting for CFDA/FDA submission.

2018

TriApex(Nanjing) Clinical Medicine was founded

TriApexPharmaceutical Research Launches OECD Qualification Certification/SEND System Online

2019

Shanghai TriApex Biotechnology Co., Ltd. was founded

TriApex passed the re-inspection by NMPA.

2020

Harborside

TriApex (Shanghai) in operation

TriApex Med Chengdu Beauty Medical (dedicated to ophthalmology) was founded.

2021

TriApex achieved group management

acquisition of Kunming KBI.

2022

a laboratory animal resource platform was founded/ layout of disease-oriented R&D (Ophthalmology/CNS/Metabolic Disease) was deepened /international business development was strengthened.

2023

more highlights…